Lupin Stock Screener | Share Price & Fundamental Analysis
LUPIN
Pharmaceuticals
Share Price NSE
₹2294.10
▼
-4.20 (-0.18%)
Share Price BSE
₹2293.55
▼
-3.05 (-0.13%)
Track Lupin share price live with TickJournal's free stock screener.
Analyze Lupin share price history trends and compare 52-week high low
levels.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Lupin Market Cap
₹102,578.78 Cr.
LUPIN P/E Ratio (TTM)
22.29
Lupin P/B Ratio
5.30
EPS (TTM)
₹71.95
Dividend Yield
0.53%
Debt to Equity
0.27
LUPIN 52 Week High
₹2357.30
Lupin 52 Week Low
₹1851.80
Operating Margin
25.00%
Profit Margin
16.37%
LUPIN Revenue (TTM)
₹7,215.00
EBITDA
₹1,883.00
Net Income
₹1,181.00
Total Assets
₹29,205.00
Total Equity
₹17,294.00
Lupin Share Price History - Stock Screener Chart
Screen LUPIN historical share price movements with interactive charts. Analyze price trends and patterns.
Lupin Company Profile - Fundamental Screener
Screen Lupin company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for LUPIN shares.
Lupin is a global pharmaceutical company producing branded and generic formulations, biotechnology products, and active pharmaceutical ingredients. Founded in 1983, it operates in over 100 markets, specializing in cardiovascular, diabetology, asthma, pediatric, central nervous system, gastrointestinal, anti-infective, and NSAID therapies. Lupin is a leader in anti-TB and cephalosporins segments. The...more
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
Chairperson/CEO
M D Gupta
ISIN
INE326A01037
Website
https://www.lupin.com/
Lupin Balance Sheet Screener
Screen LUPIN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 29,205 | 23,997 | 22,956 | 21,821 | 23,610 | 24,984 | 27,949 | 26,305 | 26,607 | 22,625 |
| Current Assets | 16,799 | 13,448 | 12,451 | 12,458 | 13,986 | 15,413 | 13,854 | 12,210 | 11,953 | 9,887 |
| Fixed Assets | 9,719 | 8,878 | 8,355 | 7,382 | 7,881 | 7,938 | 11,087 | 10,362 | 11,033 | 8,717 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 2,949 | 1,122 | 1,148 | 1,101 | 1,316 | 3,178 | 8,030 | 7,593 | 6,955 | 6,368 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 17,294 | 14,374 | 12,543 | 12,222 | 13,858 | 12,581 | 13,789 | 13,617 | 13,532 | 11,196 |
| Share Capital | 91 | 91 | 91 | 91 | 91 | 91 | 91 | 90 | 90 | 90 |
| Reserves & Surplus | 17,112 | 14,199 | 12,374 | 12,062 | 13,712 | 12,446 | 13,652 | 13,487 | 13,407 | 11,073 |
Lupin Income Statement Screener - Profit & Revenue Analysis
Screen Lupin income statement and profit fundamentals.
Analyze LUPIN quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Lupin share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7,215 | 6,921 | 6,243 | 5,619 | 5,672 | 5,539 | 5,582 | 4,924 | 5,109 | 4,980 | 4,765 | 4,368 | 4,263 | 4,106 | 3,610 |
| Expenses | 5,332 | 4,706 | 4,541 | 4,346 | 4,412 | 4,332 | 4,359 | 3,964 | 4,160 | 4,121 | 3,958 | 3,852 | 3,790 | 3,693 | 3,512 |
| EBITDA | 1,883 | 2,215 | 1,702 | 1,273 | 1,261 | 1,207 | 1,223 | 960 | 950 | 859 | 807 | 515 | 473 | 414 | 98 |
| Operating Profit % | 25.00% | 31.00% | 26.00% | 22.00% | 21.00% | 21.00% | 21.00% | 19.00% | 18.00% | 17.00% | 17.00% | 11.00% | 11.00% | 10.00% | 3.00% |
| Depreciation | 313 | 317 | 299 | 393 | 272 | 257 | 248 | 457 | 257 | 248 | 235 | 264 | 220 | 204 | 193 |
| Interest | 115 | 108 | 92 | 89 | 67 | 71 | 68 | 71 | 74 | 81 | 86 | 93 | 84 | 55 | 43 |
| Profit Before Tax | 1,522 | 2,007 | 1,416 | 896 | 1,071 | 1,055 | 993 | 498 | 736 | 630 | 559 | 259 | 246 | 210 | 2 |
| Tax | 342 | 522 | 194 | 114 | 212 | 195 | 188 | 130 | 117 | 134 | 106 | 16 | 89 | 75 | 89 |
| Net Profit | 1,181 | 1,485 | 1,222 | 782 | 859 | 860 | 806 | 368 | 619 | 495 | 453 | 242 | 158 | 135 | -87 |
| EPS | 25.74 | 32.36 | 26.70 | 16.93 | 18.75 | 18.70 | 17.58 | 7.89 | 13.47 | 10.76 | 9.94 | 5.19 | 3.38 | 2.85 | -1.96 |
Lupin Cash Flow Screener - Liquidity Fundamentals
Screen LUPIN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 3,000 | 3,648 | 1,897 | 367 | 1,822 | 1,469 | 1,666 | 1,751 | 4,114 | -382 |
| Investing Activities | -4,172 | -1,712 | -1,287 | 1,292 | -1,240 | 1,107 | -3,283 | 470 | -2,527 | -6,769 |
| Financing Activities | 1,732 | -2,184 | -337 | -1,572 | -1,885 | -891 | 744 | -1,492 | 433 | 5,836 |
| Net Cash Flow | 560 | -248 | 273 | 87 | -1,303 | 1,685 | -872 | 729 | 2,019 | -1,315 |
Lupin Shareholding Pattern Screener
See Lupin shareholding pattern with promoter, FII, and DII holdings.
Check Lupin promoter holding and ownership changes for LUPIN on TickJournal.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 46.89% | 46.90% | 46.90% | 46.92% | 46.95% | 46.96% | 46.98% | 47.01% |
| FII Holding | 21.49% | 20.49% | 21.25% | 21.46% | 22.04% | 21.50% | 19.32% | 18.28% |
| DII Holding | 25.58% | 26.55% | 25.56% | 25.41% | 24.74% | 25.09% | 26.78% | 27.76% |
| Govt Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public Holding | 5.10% | 5.12% | 5.23% | 5.10% | 5.17% | 5.29% | 5.65% | 5.70% |
| Other Holding | 0.93% | 0.94% | 1.05% | 1.10% | 1.10% | 1.15% | 1.26% | 1.23% |
| Shareholder Count | 288,931 | 280,256 | 286,604 | 283,210 | 281,988 | 279,280 | 288,537 | 280,248 |
Lupin Share Dividend Screener - Share Yield Analysis
Check Lupin dividend history with payout and yield data.
View Lupin dividend details including ex-dates and amounts for LUPIN stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹12.00 | 0.52% |
| 2024-March | ₹8.00 | 0.39% |
| 2023-March | ₹4.00 | 0.25% |
| 2022-March | ₹4.00 | 0.61% |
| 2021-March | ₹6.50 | 0.87% |
| 2020-March | ₹6.00 | 0.59% |
| 2019-March | ₹5.00 | 0.85% |
| 2018-March | ₹5.00 | 0.68% |
| 2017-March | ₹7.50 | 1.02% |
Lupin Stock Index Membership
See which indices include Lupin stock.
Check LUPIN index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE 200 EQUAL WEIGHT
BSE INDEX BSE HC
BSE INDEX BSE100
BSE INDEX BSE200
BSE INDEX BSE500
BSE INDEX BSEMOI
BSE INDEX DOL100
BSE INDEX ESG100
BSE INDEX LMI250
BSE INDEX MID150
BSE INDEX MIDCAP
BSE INDEX MIDSEL
BSE INDEX MSL400
BSE INDEX SNXT50
NIFTY 200
NIFTY 500
NIFTY ALPHA 50
NIFTY ALPHALOWVOL
NIFTY HEALTHCARE
NIFTY INDIA MFG
NIFTY LARGEMID250
NIFTY LOW VOLATILITY 50
NIFTY MID LIQ 15
NIFTY MIDCAP 100
NIFTY MIDCAP 150
NIFTY MIDCAP 50
NIFTY MIDCAP SELECT (MIDCPNIFTY)
NIFTY MIDSMALLCAP400 MOMENTUM QUALITY 100
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY MULTI MFG
NIFTY PHARMA
NIFTY SHARIAH 25
NIFTY TOTAL MKT
NIFTY200 ALPHA 30
NIFTY200MOMENTM30
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MOMENTUM 50
NIFTY500 MULTICAP
NIFTY500 SHARIAH
NIFTYM150MOMNTM50
Lupin Market Events Screener - Corporate Actions
Get Lupin corporate actions including splits, bonuses, and buybacks.
Check Lupin stock events that may affect LUPIN share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | 2.72% |
| 2025-11-06 | 2025-11-06 | Quarterly Result Announcement | NA | 2.76% |
| 2025-08-11 | 2025-08-11 | Annual General Meeting | NA | 1.23% |
| 2025-08-05 | 2025-08-05 | Quarterly Result Announcement | NA | -2.52% |
| 2025-07-25 | 2025-07-25 | Dividend | ₹ 12.00 /share | -5.80% |
| 2025-05-14 | 2025-05-14 | Quarterly Result Announcement | NA | -2.12% |
| 2025-02-11 | 2025-02-11 | Quarterly Result Announcement | NA | 1.65% |
| 2024-11-07 | 2024-11-07 | Quarterly Result Announcement | NA | 0.66% |
| 2024-08-02 | 2024-08-02 | Annual General Meeting | NA | 9.82% |
| 2024-07-16 | 2024-07-16 | Dividend | ₹ 8.00 /share | 10.68% |
| 2023-07-14 | 2023-07-14 | Dividend | ₹ 4.00 /share | 27.11% |
| 2022-07-14 | 2022-07-15 | Dividend | ₹ 4.00 /share | -5.87% |
| 2021-07-27 | 2021-07-28 | Dividend | ₹ 6.50 /share | -8.30% |
Lupin Competitors Screener - Peer Comparison
Screen LUPIN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 401,745 | 37.12 | 54,729 | 9.71% | 10,980 | 37.98 |
| Divis Laboratories | 153,096 | 62.72 | 9,712 | 18.67% | 2,191 | 33.24 |
| Torrent Pharmaceuticals | 134,871 | 59.42 | 11,539 | 6.99% | 1,911 | 32.75 |
| Lupin | 102,579 | 22.29 | 22,910 | 13.74% | 3,306 | 47.35 |
| Dr Reddys Laboratories | 100,867 | 18.40 | 33,741 | 16.73% | 5,725 | 39.36 |
| Cipla | 95,480 | 21.27 | 28,410 | 7.12% | 5,291 | 26.86 |
| Zydus Life Science | 86,420 | 17.30 | 23,511 | 18.55% | 4,615 | 41.42 |
| Mankind Pharma | 82,194 | 45.73 | 12,744 | 20.90% | 2,007 | 41.40 |
| Aurobindo Pharma | 76,904 | 22.27 | 32,346 | 9.43% | 3,484 | 64.38 |
| Alkem Laboratories | 62,521 | 25.95 | 13,458 | 3.70% | 2,216 | 42.54 |
Lupin Company Announcements - News Screener
Screen LUPIN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-06 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-04-05 | Acquisition Of Minority Shareholding In Multicare Pharmaceuticals Philippines Inc. | - |
| 2026-04-05 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
| 2026-04-03 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-04-03 | Buyback Of Shares By Multicare Pharmaceuticals Philippines Inc. A Subsidiary Company. | - |
| 2026-03-25 | Closure of Trading Window | - |
| 2026-03-25 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-03-24 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | - |
| 2026-03-19 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-03-17 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-03-07 | U.S. FDA Has Concluded An Inspection At Our Manufacturing Facility At Ankleshwar India. | - |
| 2026-03-07 | Newspaper Publication For The Information Regarding Special Window For Transfer And Dematerialization Of Physical Shares. | - |
| 2026-03-02 | Disclosure Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-02-27 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
| 2026-02-27 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-02-26 | Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised) | - |
| 2026-02-26 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-02-26 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-02-25 | Disclosure Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-02-24 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |